Our publication with relevant market data for Switzerland. This publication gives an overview of market multiples and cost of capital components per industry and includes also relevant macro-economic data used in business and other valuations such as impairment tests or purchase price allocations.
In today's global and increasingly complex environment, the ability of an organization to effectively execute a transformational event - such as an acquisition - plays a key role in enhancing an organization's value. Find out more.
The theme of this year's Swiss Biotech Report is ‘shaping change'. Biotechnology is one of many areas where change is happening fast, revolutionizing the way we help to heal, fuel, and feed the world.
In Life Sciences 4.0: Securing value through data-driven platforms, we explore how health is being reimagined as a result of scientific and technological change and rising customer expectations.
An integrated framework for leaders in turnaround situations
When data and technology expedite growth, how can dealmaking power the value equation?
EY beriet Invision beim Kauf eines Anteils an der KADI AG.
EY's CFO Survey 2018 examines the shifting role of the CFO in the digital age, identifies value creation potential and pinpoints the capabilities that will lay the foundation for sustainable success. Find our six recommendation on page 28.
The nature of transactions has evolved, and yet the majority of them still underperform for the same reason: insufficient focus on human capital. Find out about EY's step change approach to transaction services that fully addresses people to maximise deal value.